Synthetic Approaches to the New Drugs Approved During 2017.
Andrew C FlickCarolyn A LeverettHong X DingEmma McInturffSarah J FinkChristopher J HelalChristopher J O'DonnellPublished in: Journal of medicinal chemistry (2019)
New drugs introduced to the market every year represent privileged structures for particular biological targets. These new chemical entities (NCEs) provide insight into molecular recognition while serving as leads for designing future new drugs. This annual review describes the most likely process-scale synthetic approaches to 31 new chemical entities approved for the first time globally in 2017.